United States In Vitro Diagnostics (IVD) Market Outlook to 2021, New Report Launched

United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture report provides key market data on the United States In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
• Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
• 2014 company shares and distribution shares data for In Vitro Diagnostics market.
• Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics market.
• Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

• Develop business strategies by identifying the key market segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Spanning over 680 pages “United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture” report covers Introduction, In Vitro Diagnostics Market, United States, Clinical Chemistry Market, United States, Genetic Testing Market, United States, Haematology Market, United States, Histology And Cytology Market, United States, Immuno Chemistry Market, United States,  Infectious Diagnostics Market, United States, Microbiology Culture Market, United States, Overview of Key Companies in United States, In Vitro Diagnostics Market, In Vitro Diagnostics Market Pipeline Products, Financial Deals Landscape, Appendix. The report covered companies are - Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., bioMerieux S.A., Qiagen N.V., Bio-Rad Laboratories, Inc., Alere Inc., Thermo Fisher Scientific Inc., Immucor, Inc., Ortho-Clinical Diagnostics Inc., Sysmex Corporation, Cepheid, PerkinElmer, Inc.

Find more information Visit at: http://mrr.cm/o2C

Related Report:

Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture - Visit at – http://mrr.cm/o2y